ValuEngine Upgrades Reliv’ International, Inc. (RELV) to Buy
Reliv’ International, Inc. (NASDAQ:RELV) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, July 11th.
Reliv’ International (RELV) opened at 9.90 on Tuesday. The company’s 50 day moving average price is $9.18 and its 200 day moving average price is $6.76. The firm’s market capitalization is $18.27 million. Reliv’ International has a 12 month low of $3.84 and a 12 month high of $13.77.
Reliv’ International (NASDAQ:RELV) last issued its quarterly earnings data on Friday, May 12th. The company reported $0.28 earnings per share for the quarter. Reliv’ International had a negative return on equity of 0.39% and a negative net margin of 0.13%. The business had revenue of $12.78 million for the quarter. Analysts anticipate that Reliv’ International will post $0.20 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “ValuEngine Upgrades Reliv’ International, Inc. (RELV) to Buy” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/07/reliv-international-inc-relv-upgraded-to-buy-by-valuengine-updated-updated-updated.html.
About Reliv’ International
Reliv’ International, Inc is a developer, manufacturer and marketer of a line of nutritional supplements addressing nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Stock Ratings for Reliv' International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reliv' International Inc. and related stocks with our FREE daily email newsletter.